LOTEPREDNOL ETABONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Loteprednol Etabonate, and when can generic versions of Loteprednol Etabonate launch?
Loteprednol Etabonate is a drug marketed by Hikma, Sentiss, Sun Pharm, and Lupin Ltd. and is included in eight NDAs.
The generic ingredient in LOTEPREDNOL ETABONATE is loteprednol etabonate. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loteprednol Etabonate
A generic version of LOTEPREDNOL ETABONATE was approved as loteprednol etabonate by SENTISS on April 17th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOTEPREDNOL ETABONATE?
- What are the global sales for LOTEPREDNOL ETABONATE?
- What is Average Wholesale Price for LOTEPREDNOL ETABONATE?
Summary for LOTEPREDNOL ETABONATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Clinical Trials: | 47 |
Patent Applications: | 4,390 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LOTEPREDNOL ETABONATE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for LOTEPREDNOL ETABONATE |
What excipients (inactive ingredients) are in LOTEPREDNOL ETABONATE? | LOTEPREDNOL ETABONATE excipients list |
DailyMed Link: | LOTEPREDNOL ETABONATE at DailyMed |
![LOTEPREDNOL ETABONATE drug patent expirations Drug patent expirations by year for LOTEPREDNOL ETABONATE](/p/graph/s/t/LOTEPREDNOL_ETABONATE-patent-expirations.png)
![Drug Prices for LOTEPREDNOL ETABONATE](/p/graph/drug-price/LOTEPREDNOL+ETABONATE.png)
Recent Clinical Trials for LOTEPREDNOL ETABONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Price Vision Group | Phase 4 |
Kala Pharmaceuticals, Inc. | Phase 4 |
Thomas Chester, OD | Phase 4 |
Pharmacology for LOTEPREDNOL ETABONATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for LOTEPREDNOL ETABONATE
Anatomical Therapeutic Chemical (ATC) Classes for LOTEPREDNOL ETABONATE
Paragraph IV (Patent) Challenges for LOTEPREDNOL ETABONATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LOTEMAX SM | Ophthalmic Gel | loteprednol etabonate | 0.38% | 208219 | 1 | 2022-11-14 |